A groundbreaking international study has brought to light the profound and often overlooked effects of electroconvulsive therapy (ECT) as reported by the families and close friends of patients who have undergone this controversial psychiatric treatment. The research highlights alarming long-term consequences that reverberate well beyond the immediate clinical outcomes, calling into question the transparency and adequacy of current consent and disclosure practices associated with ECT.
Electroconvulsive therapy, a procedure involving the induction of controlled seizures through electrical stimulation of the brain, has been employed for decades as a treatment for severe psychiatric disorders such as depression and bipolar disorder. Despite its recognized efficacy in certain cases, this form of neuromodulation remains highly contentious due to the array of potential adverse effects that many patients and their families experience but rarely find acknowledged in clinical settings.
The cross-national study, which represents the largest survey of its kind, enlisted 286 relatives and friends from 22 different countries. It sought to capture the lived realities and nuanced perspectives of those who witness firsthand the aftermath of ECT treatment. The findings reveal a complex landscape: while 45% of respondents observed some improvement in the targeted psychiatric condition, a nearly equivalent 42% perceived a deterioration in their loved one’s mental health following the intervention.
More alarmingly, the study surfaces a pervasive decline in overall quality of life post-treatment. A staggering 61% of relatives noted this diminution, juxtaposed with 34% who believed that ECT had directly caused brain damage. The cognitive impairments reported include significant memory loss, with more than half of the respondents noting these deficits persisted for at least three years. Such enduring impairments strongly suggest permanent neurological impact, challenging the frequently claimed temporary nature of ECT-induced cognitive disruption.
The scope of side effects expressed by families extends beyond memory deficits, encompassing difficulties in concentration, emotional blunting—a state characterized by an attenuation of both positive and negative affect—and a consequential loss of independence. These effects combine to fracture interpersonal relationships deeply, with 70% of participants reporting substantial strain on familial bonds and social connections. These qualitative and quantitative insights demand a reevaluation of how these outcomes are framed within the medical discourse on ECT.
The emotional toll on caregivers and relatives emerges as a poignant theme. Many recounted experiences of profound grief due to the transformation of their loved ones, lamenting a perceived loss of identity and vibrant personality. Additionally, the added responsibility of caregiving for individuals impaired cognitively and physically places significant burdens on families, who frequently feel powerless or guilty for not preventing the treatment despite their reservations.
Tragically, the survey also recorded reports of mortality linked to ECT. Eight respondents explicitly identified ECT as the direct cause of death in a loved one, while nineteen others considered the therapy a contributing factor to fatal outcomes. This underscores a critical need for rigorous risk assessment and comprehensive informed consent protocols that encompass these severe, albeit less commonly recognized, dangers.
Academic voices involved in the study emphasize the urgency of reforming current informational and ethical frameworks surrounding ECT. Professor John Read, a leading clinical psychologist and co-author of the research, underscores that relatives bear witness to the profound and often devastating effects of ECT, which are insufficiently communicated in clinical environments. He stresses that true informed consent must encompass an honest dialogue regarding both the potential benefits and risks to patients and their families.
Dr. Chris Harrop, the study’s lead author, condemns the historical neglect of family experiences in shaping our understanding of ECT’s impacts. He describes the findings as deeply troubling and commends the bravery of the respondents who shared their stories, pointing to a profound gap in mental health services’ engagement with caregivers’ perspectives.
Voices from those directly affected by ECT further illuminate the controversy. Lisa Morrison, an ECT recipient and co-author of the study, critiques the systemic minimization of patient-reported harms, framing this as a violation of human rights. Her personal narrative highlights the paradox of treatments intended to alleviate suffering that instead exacerbate distress and familial discord. Her husband, Gary Morrison, poignantly describes the emotional and functional regression observed after ECT, lamenting the false hope often engendered by the promise of relief through electric shock.
Sarah Price Hancock, another study co-author and ECT recipient, expresses a fractured sense of relief and sorrow, recognizing the life-saving outcomes reported by some families while grieving the widespread breakdown of familial relationships documented. Her father recounts the immediate and lasting cognitive and neurological impairments experienced by his daughter, linking these to the repetitive nature of the electrical trauma inflicted during ECT sessions—a perspective that challenges commonly held clinical assurances about the safety profile of the procedure.
The study, published in the British Psychological Society’s journal Psychology and Psychotherapy: Theory, Research and Practice, calls for a paradigm shift in how ECT is presented, understood, and administered globally. It advocates for multidimensional evaluations that integrate patient narratives, family observations, and objective clinical data. Furthermore, it spotlights the necessity for mental health professionals to develop and implement protocols that facilitate truly informed consent and safeguard the rights and well-being of all parties involved.
Compiling evidence from this and related publications reveals a consistent pattern: memory loss, cognitive deficits, emotional impairment, and social dysfunction are not anomalies but frequent outcomes of ECT. These insights demand serious ethical scrutiny and mandating transparent communication within clinical practice. The ramifications extend beyond individual patients, affecting entire family systems and social networks, confounding the narrative of ECT as a straightforward therapeutic intervention.
As mental health services worldwide grapple with the challenge of treating refractory affective disorders, this emerging body of research underscores an urgent need for alternative therapeutics and support mechanisms that respect patient autonomy and familial integrity. Moving forward, clinicians must balance the potential benefits of ECT against the documented sustained harms and give equal weight to the voices of those living with its consequences.
By bringing neglected perspectives into the spotlight, this pivotal study fuels an ongoing debate—pushing for reforms that prioritize holistic understanding, transparency, and ethical responsibility in psychiatric treatment. The urgent call is clear: a comprehensive, multidisciplinary approach to mental health care, inclusive of the lived experiences of patients and their families, is essential to ethically navigating the future of ECT and other neuromodulatory practices.
Subject of Research: Electroconvulsive therapy (ECT) and its long-term effects as reported by relatives and friends of patients.
Article Title: An international survey of the relatives and friends of electroconvulsive therapy recipients.
News Publication Date: 22nd April 2024.
Web References: DOI: 10.1111/papt.20062
References: Harrop, C., Cunliffe, S., Hancock, S.P., Johnstone, L., Morrison, L., Read, J. (2024). An international survey of the relatives and friends of electroconvulsive therapy recipients. Psychology and Psychotherapy: Theory, Research and Practice.
Keywords: Electroconvulsive therapy, ECT, Psychiatric treatment, Neuromodulation, Mental health, Memory loss, Cognitive impairment, Clinical psychology, Psychiatric ethics, Depression, Bipolar disorder, Caregiver burden.
